CDBT — China Dasheng Biotechnology Co Balance Sheet

0.000.00%

Last trade - 00:00

FinancialsHighly SpeculativeMicro Cap

Annual balance sheet for China Dasheng Biotechnology Co, fiscal year end - June 30th, millions except per share.

	2005 October 31st	2006 October 31st	2007 October 31st	2008 June 30th
Period Length:	—	—	—	—
Source:		PROSPECTUS	10KSB	10-K
Standards:	—	USG	USG	USG
Status:	fx Preliminary	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	—	0.007	—	1.56
Net Total Accounts Receivable
Net Total Receivables	—	0.008	—	4.83
Total Inventory
Prepaid Expenses
Total Current Assets	—	0.036	—	8.47
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	0.004	—	1.62
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	—	0.048	0.011	20.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	—	0.049	0.079	1.54
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	—	0.049	0.079	4.56
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	—	0	-0.068	15.7
Total Liabilities & Shareholders' Equity	—	0.049	0.011	20.3
Total Common Shares Outstanding